Cargando…
Development of modified nucleosides that have supremely high anti-HIV activity and low toxicity and prevent the emergence of resistant HIV mutants
An idea to use 4′-C-substituted-2′-deoxynucleoside derivatives was proposed based on a working hypothesis to solve the problems of existing acquired immune deficiency syndrome chemotherapy (highly active antiretroviral therapy). Subsequent studies have successfully proved the validity of the idea an...
Autor principal: | OHRUI, Hiroshi |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
The Japan Academy
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3066546/ https://www.ncbi.nlm.nih.gov/pubmed/21422739 http://dx.doi.org/10.2183/pjab.87.53 |
Ejemplares similares
-
Intriguing Antiviral Modified Nucleosides: A Retrospective
View into the Future Treatment of COVID-19
por: Ami, Ei-ichi, et al.
Publicado: (2021) -
Supreme Emergencies Without the Bad Guys
por: Sandin, Per
Publicado: (2008) -
In-silico designing of acyclic nucleoside phosphonates and their anti-HIV potential
por: Yadav, Dipti, et al.
Publicado: (2012) -
Diverse models for anti-HIV activity of purine nucleoside analogs
por: Khatri, Naveen, et al.
Publicado: (2015) -
Preclinical and clinical development of the anti-HIV, anti-HBV oxathiolane nucleoside analog emtricitabine
por: Painter, George R., et al.
Publicado: (2003)